These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 10465066)
1. A soluble factor produced by macrophages mediates the neurotoxic effects of HIV-1 Tat in vitro. Brana C; Biggs TE; Barton CH; Sundstrom LE; Mann DA AIDS; 1999 Aug; 13(12):1443-52. PubMed ID: 10465066 [TBL] [Abstract][Full Text] [Related]
2. A macrophage hippocampal slice co-culture system: application to the study of HIV-induced brain damage. Brana C; Biggs TE; Mann DA; Sundstrom LE J Neurosci Methods; 1999 Aug; 90(1):7-11. PubMed ID: 10517268 [TBL] [Abstract][Full Text] [Related]
3. Cytotoxic effects of exposure to the human immunodeficiency virus type 1 protein Tat in the hippocampus are enhanced by prior ethanol treatment. Self RL; Mulholland PJ; Harris BR; Nath A; Prendergast MA Alcohol Clin Exp Res; 2004 Dec; 28(12):1916-24. PubMed ID: 15608609 [TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus-encoded Tat activates glycogen synthase kinase-3beta to antagonize nuclear factor-kappaB survival pathway in neurons. Sui Z; Sniderhan LF; Fan S; Kazmierczak K; Reisinger E; Kovács AD; Potash MJ; Dewhurst S; Gelbard HA; Maggirwar SB Eur J Neurosci; 2006 May; 23(10):2623-34. PubMed ID: 16817865 [TBL] [Abstract][Full Text] [Related]
5. Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline. Kim BO; Liu Y; Ruan Y; Xu ZC; Schantz L; He JJ Am J Pathol; 2003 May; 162(5):1693-707. PubMed ID: 12707054 [TBL] [Abstract][Full Text] [Related]
6. Anti-tat Hutat2:Fc mediated protection against tat-induced neurotoxicity and HIV-1 replication in human monocyte-derived macrophages. Kang W; Marasco WA; Tong HI; Byron MM; Wu C; Shi Y; Sun S; Sun Y; Lu Y J Neuroinflammation; 2014 Nov; 11():195. PubMed ID: 25416164 [TBL] [Abstract][Full Text] [Related]
7. Tat, a human immunodeficiency virus-1-derived protein, augments excitotoxic hippocampal injury in neonatal rats. Wang P; Barks JD; Silverstein FS Neuroscience; 1999 Jan; 88(2):585-97. PubMed ID: 10197777 [TBL] [Abstract][Full Text] [Related]
8. HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors. Johnston JB; Zhang K; Silva C; Shalinsky DR; Conant K; Ni W; Corbett D; Yong VW; Power C Ann Neurol; 2001 Feb; 49(2):230-41. PubMed ID: 11220743 [TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-alpha-mediated neurotoxicity. Buscemi L; Ramonet D; Geiger JD Neurobiol Dis; 2007 Jun; 26(3):661-70. PubMed ID: 17451964 [TBL] [Abstract][Full Text] [Related]
10. Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum. Bansal AK; Mactutus CF; Nath A; Maragos W; Hauser KF; Booze RM Brain Res; 2000 Oct; 879(1-2):42-9. PubMed ID: 11011004 [TBL] [Abstract][Full Text] [Related]
11. Biocompatibility of silicon-based arrays of electrodes coupled to organotypic hippocampal brain slice cultures. Kristensen BW; Noraberg J; Thiébaud P; Koudelka-Hep M; Zimmer J Brain Res; 2001 Mar; 896(1-2):1-17. PubMed ID: 11277967 [TBL] [Abstract][Full Text] [Related]
12. HIV secreted protein Tat prevents long-term potentiation in the hippocampal CA1 region. Behnisch T; Francesconi W; Sanna PP Brain Res; 2004 Jun; 1012(1-2):187-9. PubMed ID: 15158177 [TBL] [Abstract][Full Text] [Related]
13. The human immunodeficiency virus type 1 regulatory protein Tat inhibits interferon-induced iNos activity in a murine macrophage cell line. Barton CH; Biggs TE; Mee TR; Mann DA J Gen Virol; 1996 Aug; 77 ( Pt 8)():1643-7. PubMed ID: 8760410 [TBL] [Abstract][Full Text] [Related]
14. Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine sensitive-site on the N-methyl-D-aspartate receptor. Prendergast MA; Rogers DT; Mulholland PJ; Littleton JM; Wilkins LH; Self RL; Nath A Brain Res; 2002 Nov; 954(2):300-7. PubMed ID: 12414113 [TBL] [Abstract][Full Text] [Related]
15. Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor. Aksenov MY; Aksenova MV; Nath A; Ray PD; Mactutus CF; Booze RM Neurotoxicology; 2006 Mar; 27(2):217-28. PubMed ID: 16386305 [TBL] [Abstract][Full Text] [Related]
16. The human immunodeficiency virus type-1 transcription factor Tat produces elevations in intracellular Ca2+ that require function of an N-methyl-D-aspartate receptor polyamine-sensitive site. Self RL; Mulholland PJ; Nath A; Harris BR; Prendergast MA Brain Res; 2004 Jan; 995(1):39-45. PubMed ID: 14644469 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of HIV-1 Tat induced neurotoxicity in rat cortical cell culture. Pérez A; Probert AW; Wang KK; Sharmeen L J Neurovirol; 2001 Feb; 7(1):1-10. PubMed ID: 11519477 [TBL] [Abstract][Full Text] [Related]
18. CCR2 mediates increases in glial activation caused by exposure to HIV-1 Tat and opiates. El-Hage N; Wu G; Ambati J; Bruce-Keller AJ; Knapp PE; Hauser KF J Neuroimmunol; 2006 Sep; 178(1-2):9-16. PubMed ID: 16831471 [TBL] [Abstract][Full Text] [Related]
19. Tubulin-mediated binding of human immunodeficiency virus-1 Tat to the cytoskeleton causes proteasomal-dependent degradation of microtubule-associated protein 2 and neuronal damage. Aprea S; Del Valle L; Mameli G; Sawaya BE; Khalili K; Peruzzi F J Neurosci; 2006 Apr; 26(15):4054-62. PubMed ID: 16611822 [TBL] [Abstract][Full Text] [Related]
20. Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro. Gurwell JA; Nath A; Sun Q; Zhang J; Martin KM; Chen Y; Hauser KF Neuroscience; 2001; 102(3):555-63. PubMed ID: 11226693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]